Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2026-05-27 @ 8:09 AM
Study NCT ID:
NCT01271504
Status:
COMPLETED
Last Update Posted:
2021-05-12
First Post:
2011-01-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma
Sponsor:
Eisai Inc.
Organization: